CRISPR Therapeutics AG (NASDAQ:CRSP)

121.00
Delayed Data
As of Jul 30
 +2.00 / +1.68%
Today’s Change
76.71
Today|||52-Week Range
220.20
-20.97%
Year-to-Date

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 165.00, with a high estimate of 220.00 and a low estimate of 117.00. The median estimate represents a +36.36% increase from the last price of 121.00.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.73
Sales
$1.4M
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -118.34%
 
 
 
 
 
 
Growthannually 169.03%
 
 
 
 
 
 

Sales

Growthquarterly -99.85%
 
 
 
 
 
 
Growthannually 125,614.13%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.